Healthcare provider profile · identity verified

Carah Howe, MD

Family Practice · LINDALE, TX · NPI 1609288091

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	472	126
Amlodipine Besylate	Amlodipine Besylate	463	126
Lisinopril	Lisinopril	428	111
Levothyroxine Sodium	Levothyroxine Sodium	398	96
Gabapentin	Gabapentin	373	101
Losartan Potassium	Losartan Potassium	353	95
Rosuvastatin Calcium	Rosuvastatin Calcium	304	85
Omeprazole	Omeprazole	273	82
Pantoprazole Sodium	Pantoprazole Sodium	233	62
Tramadol Hcl	Tramadol Hcl	225	39
Montelukast Sodium	Montelukast Sodium	221	62
Hydrochlorothiazide	Hydrochlorothiazide	207	57
Sertraline Hcl	Sertraline Hcl	201	45
Metformin Hcl	Metformin Hcl	195	58
Albuterol Sulfate Hfa	Albuterol Sulfate	181	68
Metoprolol Succinate	Metoprolol Succinate	160	38
Trazodone Hcl	Trazodone Hcl	155	40
Simvastatin	Simvastatin	153	45
Buspirone Hcl	Buspirone Hcl	152	42
Ozempic	Semaglutide	150	25
Duloxetine Hcl	Duloxetine Hcl	146	37
Potassium Chloride	Potassium Chloride	145	51
Escitalopram Oxalate	Escitalopram Oxalate	139	34
Furosemide	Furosemide	138	47
Tamsulosin Hcl	Tamsulosin Hcl	135	43
Fluoxetine Hcl	Fluoxetine Hcl	133	27
Bupropion Xl	Bupropion Hcl	128	28
Fluticasone Propionate	Fluticasone Propionate	102	45
Metoprolol Tartrate	Metoprolol Tartrate	101	26
Meloxicam	Meloxicam	100	35
Prednisone	Prednisone	99	49
Pravastatin Sodium	Pravastatin Sodium	95	29
Pregabalin	Pregabalin	87	16
Jardiance	Empagliflozin	83	20
Eliquis	Apixaban	82	21
Carvedilol	Carvedilol	80	24
Clonazepam	Clonazepam	79	14
Glipizide	Glipizide	78	31
Metformin Hcl Er	Metformin Hcl	78	22
Synthroid	Levothyroxine Sodium	77	22
Tizanidine Hcl	Tizanidine Hcl	77	19
Alprazolam	Alprazolam	75	20
Zolpidem Tartrate	Zolpidem Tartrate	75	20
Ondansetron Odt	Ondansetron	74	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	73	60
Trulicity	Dulaglutide	73	11
Lorazepam	Lorazepam	72	suppressed
Atenolol	Atenolol	71	19
Famotidine	Famotidine	68	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	67	28
Ezetimibe	Ezetimibe	66	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	16
Glimepiride	Glimepiride	63	13
Hydralazine Hcl	Hydralazine Hcl	63	15
Oxybutynin Chloride Er	Oxybutynin Chloride	63	11
Doxycycline Hyclate	Doxycycline Hyclate	60	48
Allopurinol	Allopurinol	58	17
Alendronate Sodium	Alendronate Sodium	55	17
Esomeprazole Magnesium	Esomeprazole Magnesium	55	15
Triamcinolone Acetonide	Triamcinolone Acetonide	55	34
Cephalexin	Cephalexin	54	37
Citalopram Hbr	Citalopram Hydrobromide	50	16
Mounjaro	Tirzepatide	49	suppressed
Xarelto	Rivaroxaban	45	suppressed
Clopidogrel	Clopidogrel Bisulfate	44	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	11
Methocarbamol	Methocarbamol	41	22
Linzess	Linaclotide	40	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	39	12
Naproxen	Naproxen	39	12
Pioglitazone Hcl	Pioglitazone Hcl	39	12
Ropinirole Hcl	Ropinirole Hcl	39	12
Temazepam	Temazepam	39	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	36	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	34	15
Fluconazole	Fluconazole	32	17
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Mupirocin	Mupirocin	31	17
Estradiol	Estradiol	30	suppressed
Valacyclovir	Valacyclovir Hcl	30	15
Memantine Hcl	Memantine Hcl	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Fenofibrate	Fenofibrate	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Valsartan	Valsartan	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Nystatin	Nystatin	25	14
Ondansetron Hcl	Ondansetron Hcl	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Azelastine Hcl	Azelastine Hcl	22	13
Clobetasol Propionate	Clobetasol Propionate	22	11
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Diazepam	Diazepam	21	suppressed
Finasteride	Finasteride	20	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	11
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Cefuroxime	Cefuroxime Axetil	19	14
Diltiazem 24hr Er	Diltiazem Hcl	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Torsemide	Torsemide	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Baclofen	Baclofen	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	12
Terazosin Hcl	Terazosin Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Primidone	Primidone	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Risperidone	Risperidone	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error